Consistent with these findings, the RNA and protein (8/10, 80%) levels of YTHDC1 in ovarian cancer tissues were found to be remarkably lower compared to benign ovarian tissues (Figure 1D-E). This evidence concerns the gene YTHDC1 and ovarian carcinoma.